Long-Term Safety, Tolerability and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria
Clinical trial NCT06298955 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06298955
- Sponsor
- Omeros Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-19
- Primary completion
- 2026-12-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.